tirzepatide through LillyDirect
Last updated 2026-08-20 — the price on this page
Can you get tirzepatide through LillyDirect, and what does it cost?
LillyDirect supplies tirzepatide as the branded, FDA-approved product. halfrx records $299 a month all-in once titrated, read from LillyDirect's own published page on 2026-08-20. That is the maintenance figure rather than an introductory rate, because the starting dose is not the dose anyone stays on. It is not the only route: halfrx records 5 verified ways to buy tirzepatide, and 3 of them are cheaper — the lowest at $178 a month. Nothing sits on LillyDirect's public record here: no FTC action, no state action, no failing BBB grade and no matched FDA warning letter.
What LillyDirect gets right, and what it does not
Each line is read from a cited source rather than from a reviewer's impression, and these are LillyDirect's own — nothing here is shared with the other sellers of this molecule.
- +You buy from Eli Lilly itself. No telehealth membership, no cancellation policy to fight, no compounding pharmacy in the chain.
- +Zepbound vials from $299/mo at the starter dose against a $1,086 list price — the largest manufacturer discount in the category.
- +Foundayo (orforglipron) from $149/mo is the cheapest branded FDA-approved weight-loss drug available anywhere, and it is a daily pill.
- +Tirzepatide delivers the strongest average weight loss of any approved molecule.
- −Lilly molecules only. If tirzepatide does not suit you, this channel has no semaglutide alternative.
- −No clinical programme, coaching or side-effect management — it is a pharmacy, not a weight service.
- −Self-pay pricing is dose-scaled, so the $299 and $149 headlines are starter doses, not maintenance.
- −Both products price maintenance doses on a 45-day refill condition, and Lilly counts a month as 28 days — so the advertised figure is a floor that assumes you never lapse.
What tirzepatide does, on the trial evidence
20.9% average weight loss in SURMOUNT-1: about 20.9% mean weight loss at the 15 mg dose over 72 weeks, the trial behind Zepbound, the approved product built on this molecule.
FDA status of the approved product: FDA approved for chronic weight management and obstructive sleep apnea, since 2023-11-08.
List price of the approved product is $1,086 a month, against $299 here — a gap of $787 a month, or $9,444 a year, which is the whole reason this route exists.
Which products tirzepatide is sold as, and what each costs direct
| Product | Direct price | Maintenance dose | Checked |
|---|---|---|---|
| Zepbound | $449 | 5 mg, 10 mg or 15 mg once weekly | 2026-08-19 |
| Mounjaro | $499 | 5 mg to 15 mg once weekly, set by blood sugar control | 2026-08-24 |
LillyDirect publishes one figure covering all 2 of these, which is why this page is keyed on the molecule rather than a brand: a per-brand page would be repeating the same verified number under 2 different titles.
What you are actually buying each month
Zepbound
One injection a week. The label puts 5 weeks between the first dose and the maintenance dose, so an advertised monthly figure buys a starting dose for the first few months and the maintenance dose after that — which is why the price above is the maintenance one.
| Weeks | Dose | Note |
|---|---|---|
| 1–4 | 2.5 mg | Initiation only. The label says in as many words that 2.5 mg is not approved as a maintenance dose. |
| 5–8 | 5 mg | The first dose that can be kept long term. |
| 9–12 | 7.5 mg | Optional. Increases come in 2.5 mg steps, no sooner than every 4 weeks. |
| 13–16 | 10 mg | A maintenance dose, and the lowest one approved for sleep apnea. |
| 17–20 | 12.5 mg | Optional. |
| 21 and on | 15 mg | Maximum. Reachable no earlier than week 21. |
Maintenance: 5 mg, 10 mg or 15 mg once weekly. FDA prescribing information for Zepbound (tirzepatide)
Mounjaro
One injection a week. The label puts 5 weeks between the first dose and the maintenance dose, so an advertised monthly figure buys a starting dose for the first few months and the maintenance dose after that — which is why the price above is the maintenance one.
| Weeks | Dose | Note |
|---|---|---|
| 1–4 | 2.5 mg | Initiation. |
| 5–8 | 5 mg | — |
| 9 and on | 7.5 mg → 15 mg | 2.5 mg steps, no sooner than every 4 weeks, if glycaemic control needs it. |
Maintenance: 5 mg to 15 mg once weekly, set by blood sugar control. FDA prescribing information for Mounjaro (tirzepatide, diabetes label)
Why LillyDirect rather than the cheapest route
Computed for this seller against every other verified route to the same molecule, so it is a different answer on every one of these pages.
- Where it sits on price
- 4th of 5 verified routes, $121 a month above Mochi Health at $178 — $1,452 over a year, which is the number the choice actually turns on.
- Like for like
- No cheaper route is the same kind of product, so the gap above is a comparison between different things rather than a straight saving.
- What the money buys besides the drug
- Care model: pharmacy. Where a direct-from-maker route is cheaper, that is the difference being paid for — a pharmacy ships a box, a provider also employs the clinician who writes the script.
Other verified routes to tirzepatide
The pages ranking for this question cover one seller. Cheapest first, each with the date it was read.
| Route | A month | What it is | Checked |
|---|---|---|---|
| Mochi Health | $178 | compounded, not FDA approved | 2026-08-19 |
| Compounded tirzepatide | $200 | compounded, not FDA approved | 2026-06-10 |
| Noom Med | $249 | compounded, not FDA approved | 2026-08-20 |
| Zepbound | $449 | direct from the maker | 2026-08-19 |
This page exists only where LillyDirect actually supplies tirzepatide in the same form the medication is sold in — sharing a molecule is not the same as selling the product. Every figure is read from the seller's own page on the date shown.